News und Analysen
1 Dividend Growth Stock to Buy and Hold for 10 Years
If there is one thing income investors like more than regular dividend payouts, it's regular and growing dividend payouts. Not every corporation can offer that, of course. Some will eventually
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now
The stock market has its ups and downs -- and if you stay invested for decades, you will likely experience your fair share of both bull and bear markets. At the same time, by investing in a diverse
Is Pfizer Stock a Buy?
Shares of pharmaceutical giant Pfizer (NYSE: PFE) have been steadily sliding lower over the past year as revenue and profits from the pandemic's vaccine boom dry up. Today, the stock has seemingly
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Believe it or not, we're nearly halfway through this decade. The healthcare sector could be in store for monumental changes over the next few years.
These changes should present great opportunities
2 Beaten-Down Dividend Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade
The benchmark S&P 500 index is up an exciting 25.8% over the past year, but many of its components haven't participated in the gains. Nvidia and other members of the "Magnificent Seven" have been
2 Stocks Down More Than 30% to Buy Right Now
The S&P 500 is soaring as this bull market roars on, but some stocks, even those that have rebounded in recent times, still are trading at much lower levels than in the past. In fact, two stocks
Agilent’s ESG Report Highlights Expansion of Solutions to Help Labs Manage Their Environmental Footprint
Agilent Technologies Inc. (NYSE: A) today released the company’s annual ESG report, showcasing a comprehensive and growing set of sustainable solutions that enable hundreds of thousands of labs
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
It's obvious why Pfizer (NYSE: PFE) is eager to produce a medicine like Wegovy, Novo Nordisk's (NYSE: NVO) smash-hit obesity therapy that's essentially a slightly different version of its type 2
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
If you're looking to pump up your passive income stream, there are a handful of high-yield dividend stocks that deserve your attention. AbbVie (NYSE: ABBV), Ares Capital (NASDAQ: ARCC), and Realty
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) recently excited the medical community with clinical trial results from an experimental diabetes treatment it's developing. In a nutshell, it looks like a
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
Would you like to widen the stream of passive income you can expect each year? Managing rental property is an option, but most retirees find this method less passive than they would like it to be.
Is UnitedHealth Group Stock a Millionaire Maker?
Making a million dollars from a single stock sounds like it could be an unrealistic goal. But if you pick a good growth stock, which also pays a dividend, and hold on to it for the long haul, it's
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
Investors looking for high-yield dividend stocks to buy now should turn their attention toward the healthcare sector: Three relatively reliable drugmakers are trading near their 52-week lows.
Their
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
Nearly everything is going right these days for Eli Lilly (NYSE: LLY). Sales and profits have been soaring. So has the share price, jumping more than 50% year to date after a 59% gain in 2023. Lilly
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
The power of compounding is very real. It is a process that takes time, as dividend investing is not about year 1 dividend income, but rather about year 10+. In today's video, we will look at the
Where Will Amgen Be in 5 Years?
Amgen (NASDAQ: AMGN) is a top drugmaker whose shares have risen by more than 70% in five years, which is a bit shy of the S&P 500's 90% gain over that stretch. With some promising products in its
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY).
Both companies
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation
Buying a stock with the intention of never selling it, or perhaps only selling it in a few decades, requires a level of conviction that most investments simply don't warrant. It's not enough to
2 Dividend Stocks That Could Pay You for Life
People invest in dividend stocks for various reasons. Some want the passive income; others reinvest the cash to boost long-term returns; still others find that corporations that can dish out regular
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
The S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark index has participated in the rally. A handful of terrific healthcare stocks have fallen more than
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Have you ever felt anxiety about clicking the final button to buy a stock? Some investors agonize over their decisions. It doesn't have to be that way, though, if you find the right stocks.
Three
Is It Too Late to Buy Pfizer Stock?
Are Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its recent stint of unprofitability and a
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Few industries are more essential than healthcare. That makes it an excellent place to look for stocks that can perform well over extended periods since the basic services they offer are unlikely to
Trust for the National Mall and Humana Bring Pickleball Back to the National Mall for Second Year with an Expanded Footprint
The Trust for the National Mall, Humana (NYSE: HUM), and the Humana Foundation announced today that the National Mall of Pickleball is returning to America’s Front Yard, the National Mall, for a
University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky
The University of Louisville’s College of Business recently released the results of a study that evaluated Humana’s economic and community impact on Kentucky.
This press release features